Filana Therapeutics FLNA
NASDAQ FLNA
$0.65 -0.01 (-0.89%)
As of: Oct 23, 2026 · 3:59 PM EDT

Filana Therapeutics (FLNA) Gains from Sales and Divestitures (2020)

Updated

Filana Therapeutics (FLNA) posted Gains from Sales and Divestitures of $346,000 for FY2020.

Analysis

Filana Therapeutics (FLNA) Gains from Sales and Divestitures (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Filana Therapeutics 30.53 Mn -340.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 246,000.00
Mar 31, 2020 100,000.00
API Access

Filana Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=FLNA&period=max&api_key=YOUR_API_KEY